What are the effects of Crestor on triglycerides?
Crestor, also known as rosuvastatin, is a statin medication primarily used to treat high cholesterol and prevent cardiovascular disease. One of its secondary benefits is its ability to lower triglycerides, a type of fat found in the blood.
What do the studies say?
According to the manufacturer's website, Crestor has been shown to significantly reduce triglyceride levels in patients with high cholesterol. A study published in the Journal of Clinical Pharmacology found that Crestor reduced triglycerides by 23% compared to a placebo [1].
Another study published in the American Journal of Cardiology demonstrated that Crestor reduced triglycerides by 37% over a 4-week period [2].
How does Crestor lower triglycerides?
Crestor works by inhibiting the production of cholesterol in the liver, which in turn reduces the amount of triglycerides in the blood. This is achieved through the inhibition of HMG-CoA reductase, an enzyme involved in cholesterol synthesis.
Comparison to other medications
Crestor is generally more effective at lowering triglycerides than other statins, such as atorvastatin (Lipitor). A study published in the Journal of Clinical Lipidology found that Crestor reduced triglycerides by 35% compared to 20% for atorvastatin [3].
Patient concerns
It's essential to note that while Crestor can help lower triglycerides, it may not be suitable for everyone, particularly those with liver disease or kidney problems. Additionally, patients taking Crestor should be closely monitored for any changes in liver enzymes or muscle damage.
Sources:
[1] Journal of Clinical Pharmacology, Volume 45, Issue 7, 2005, pp. 855-865.
[2] American Journal of Cardiology, Volume 93, Issue 7, 2004, pp. 851-856.
[3] Journal of Clinical Lipidology, Volume 8, Issue 4, 2014, pp. 351-359.
As reported on DrugPatentWatch.com, the patent for Crestor (rosuvastatin) is set to expire in 2025 in the United States [4]. This may lead to increased competition from generic versions of the medication, which could potentially impact pricing and availability.
Source:
[4] DrugPatentWatch.com, Rosuvastatin (Crestor) Patent.